Cargando…
Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360452/ https://www.ncbi.nlm.nih.gov/pubmed/37484877 http://dx.doi.org/10.1159/000531225 |
| _version_ | 1785076106161815552 |
|---|---|
| author | Kudo, Masatoshi |
| author_facet | Kudo, Masatoshi |
| author_sort | Kudo, Masatoshi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10360452 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | S. Karger AG |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103604522023-08-01 Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma Kudo, Masatoshi Liver Cancer Editorial S. Karger AG 2023-05-24 /pmc/articles/PMC10360452/ /pubmed/37484877 http://dx.doi.org/10.1159/000531225 Text en © 2023 The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
| spellingShingle | Editorial Kudo, Masatoshi Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma |
| title | Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma |
| title_full | Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma |
| title_fullStr | Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma |
| title_full_unstemmed | Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma |
| title_short | Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma |
| title_sort | adjuvant atezolizumab-bevacizumab after resection or ablation for hepatocellular carcinoma |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360452/ https://www.ncbi.nlm.nih.gov/pubmed/37484877 http://dx.doi.org/10.1159/000531225 |
| work_keys_str_mv | AT kudomasatoshi adjuvantatezolizumabbevacizumabafterresectionorablationforhepatocellularcarcinoma |